Maldives vs Papua New Guinea: Share of people with HIV who receive antiretroviral therapy
Maldives
48.0%
in 2024
Papua New Guinea
46.0%
in 2024
Maldives rank
124th
Papua New Guinea rank
127th
Share of people with HIV who receive antiretroviral therapy over time
- Maldives
- Papua New Guinea
How they compare
Maldives currently reports 48.0% against 46.0% in Papua New Guinea, a difference of 2.0%.
The two have swapped places 5 times across 25 shared years of data; in 2000 it was Papua New Guinea ahead.
Maldives ranks 124th and Papua New Guinea ranks 127th of 143 countries.
Across the 3 decades both report, Maldives averaged higher in 2 and Papua New Guinea in 1.
Head to head by decade
| Decade | Maldives | Papua New Guinea | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 21.0% | 3.4% | 17.6% | Maldives |
| 2010s | 25.0% | 26.5% | 1.5% | Papua New Guinea |
| 2020s | 43.6% | 41.8% | 1.8% | Maldives |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of people with hiv who receive antiretroviral therapy, Maldives or Papua New Guinea?
- Maldives, at 48.0% against 46.0% in Papua New Guinea as of 2024.
- What is the difference in share of people with hiv who receive antiretroviral therapy between Maldives and Papua New Guinea?
- 2.0%, with Maldives ahead.
- How many years of comparable data are there for Maldives and Papua New Guinea?
- 25 years are reported by both, from 2000 to 2024.
- How do Maldives and Papua New Guinea rank globally for share of people with hiv who receive antiretroviral therapy?
- Maldives ranks 124th and Papua New Guinea ranks 127th of 143 countries.
- Where does this data come from?
- UNAIDS estimates, via World Bank (2026) – processed by Our World in Data, published as Share of people with HIV who receive antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Antiretroviral therapy is a combination of several antiretroviral medicines, used to slow the rate at which HIV multiplies inside the body.